Skip to content

Advancing Real-World Data to Generate Regulatory Grade Real-World Evidence in Oncology

Advancing Real-World Data to Generate Regulatory Grade Real-World Evidence in Oncology

Tuesday, February 20th, 2024
9:00AM – 4:00PM ET

The meeting will also be streamed virtually

Click to Watch

This collaborative public event, hosted by Aetion, Duke-Margolis Center for Health Policy, Friends of Cancer Research, and Reagan-Udall Foundation for the FDA will brought together thought leaders, experts, and industry representatives to explore the current gaps in real-world data (RWD) and strategies to optimize its potential.

  • Workshop Highlights:
    • A keynote address by Mark McClellan, M.D., PhD., former FDA Commissioner and Administrator for the Centers for Medicare and Medicaid Services
  • Sessions Highlights:
    • The opportunities and limitations of RWD
    • Strategies to enrich RWD sets
    • Role of primary data collection in oncology